TNDM logo

TNDM

Tandem Diabetes Care Inc.

$21.28
+$1.78(+9.13%)
65
Overall
40
Value
90
Tech
--
Quality
Market Cap
$1.11B
Volume
3.27M
52W Range
$9.98 - $38.28
Target Price
$21.14

Company Overview

Mkt Cap$1.11BPrice$21.28
Volume3.27MChange+9.13%
P/E Ratio-11.6Open$19.48
Revenue$940.2MPrev Close$19.50
Net Income$-96.0M52W Range$9.98 - $38.28
Div YieldN/ATarget$21.14
Overall65Value40
Quality--Technical90

No chart data available

About Tandem Diabetes Care Inc.

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Sector: Healthcare
Industry: Medical Devices

Latest News

Bernstein Keeps Their Hold Rating on Tandem Diabetes Care (TNDM)

Bernstein analyst Lee Hambright maintained a Hold rating on Tandem Diabetes Care yesterday and set a price target of $18.00. Hambright covers the H...

TipRanks Auto-Generated Intelligence Newsdesk3 days ago

Barclays Reaffirms Their Buy Rating on Tandem Diabetes Care (TNDM)

TipRanks Auto-Generated Intelligence Newsdesk5 days ago

Tandem Diabetes Care Q3 2025 Earnings: Record Sales & Growth

TipRanks Auto-Generated Newsdesk16 days ago

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM), Lemaitre Vascular (LMAT) and Shattuck Labs (STTK)

Howard Kim16 days ago

Stifel Nicolaus Reaffirms Their Hold Rating on Tandem Diabetes Care (TNDM)

TipRanks Auto-Generated Intelligence Newsdesk16 days ago
ABCD
1SymbolPriceChangeVol
2TNDM$21.28+9.1%3.27M
3
4
5
6

Get Tandem Diabetes Care Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.